Treatment News : Neurocognitive Impairment Tests Often Miss Milder Cases

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » October 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


October 17, 2013

Neurocognitive Impairment Tests Often Miss Milder Cases

The current screening tools used to detect neurocognitive impairment among people with HIV often let milder cases fall through the cracks. Publishing their findings in the journal AIDS, researchers conducted a literature review of 31 previously published studies to determine how successfully the common diagnostic tools could uncover less severe cases of impairment.

Before the era of antiretrovirals that began in the mid-1990s, severe cognitive impairment was widespread among the HIV population. Today milder cases are more the norm, and as many as half or more of people with HIV experience some form of impairment.

The researchers found that the two most popular tests, the HIV Dementia Scale and the International HIV Dementia Scale, could recognize severe neurocognitive impairment but fell short when it came to detecting more mild cases. The researchers found they could not recommend any of the available diagnostics for milder cases of neurocognitive impairment.

“With the prevalence of milder forms of [HIV-associated neurocognitive disorders, or HAND] increasing, and limited resources available for formal neuropsychological examinations, there is a critical need to be able to screen and identify people with HAND,” Sean B. Rourke, PhD, a neuropsychologist who heads the Neurobehavioral Research Unit at St. Michael’s Hospital in Toronto and who is one of the study’s authors, said in a release. “Improved screening tools could go a long way in improving the care, quality of life and study of treatment interventions of individuals living with HIV and AIDS.”

To read a release on the study, click here.

To read the study, click here.

Search: neurocognitive impairment, HIV-associated neurocognitive disorders, HIV, HIV Dementia Scale, International HIV Dementia Scale, HAND, Sean Rourke, St. Michael's Hospital.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.